Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: besttrader who wrote (19028)	4/27/2001 12:26:14 PM
From: Dave Gore	Read Replies (2) \| Respond to of 37746

Knight, no offense but you should do a little more DD before you invest. Of course these are lozenges, reading the press release would have told you that. It also tells you that they have conducted tests for seven months, so I would think they don't taste too bad. They are mint and euchalypus flavored. Couldn't taste worse than the coffee most people drink...lol! SUGGEST YOU READ THIS....newset Press Release (not the whole release) (REUTERS) Star Scientific developing tobacco lozenge Star Scientific developing tobacco lozenge By Brad Dorfman NEW YORK, April 27 (Reuters) - Upstart tobacco company Star Scientific Inc. <STSI.O> is hoping smokers will swallow the idea of getting their nicotine in a lozenge. The company is developing a smokeless hard tobacco product that it calls a "cigalett" for use in places where smoking is restricted. The company said Friday that it would introduce the product, which contains tobacco mixed with eucalyptus an mint flavorings, under the name Ariva. A spokeswoman could not say when the product would be launched. Chester, Virginia-based Star said it has reached an agreement giving Brown & Williamson Tobacco Corp. exclusive rights to sell the lozenges under its own brand. Star plans to sell the lozenges under the Ariva brand. B&W, a unit of British American Tobacco Plc <BATS.L>, is the No. 3 U.S. cigarette maker. Ariva will be the first hard smokeless tobacco product developed in the U.S. that is "both taste-acceptable and responsive to the needs of adult smokers who want an alternative to cigarettes in the many smoke-free environments they confront on a daily basis," Paul Perito, Star chairman and president, said. Star said Ariva contains less of the cancer-causing toxins, TSNAs, than conventional smokeless tobacco products, but a spokeswoman acknowledged that there is no empirical evidence that reducing the toxins lowers the risk of cancer. Ariva, which is about the size of a Tic-Tac mint, would contain at least 60 percent tobacco. A recent Supreme Court ruling on tobacco regulation could prohibit the Food and Drug Administration from regulating the lozenges.